Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 106 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Adagrasib for previously treated KRAS G12C mutated advanced non-small-cell lung cancer	Adagrasib (MRTX-849)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2023	View \| Download
Alectinib adjuvant therapy for ALK-positive non-small cell lung cancer	Alectinib (Alecensa)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2023	View \| Download
AMG 510 for KRAS G12c mutated metastatic non-small cell lung cancer - after prior standard therapy	Sotorasib (AMG 510)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2020	View \| Download
Amivantamab for advanced non-small-cell lung cancer	Amivantamab (JNJ-6372; JNJ-61186372)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2021	View \| Download
Amivantamab with chemotherapy for previously untreated advanced EGFR exon 20 insertion mutations positive non-small cell lung cancer	Amivantamab (JNJ-6372; JNJ-61186372) , Chemotherapy	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2022	View \| Download
Amivantamab with lazertinib for previously untreated locally advanced or metastatic non-small-cell lung cancer	Amivantamab (JNJ-6372; JNJ-61186372) , Lazertinib	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2023	View \| Download
Atezolizumab for previously untreated recurrent or advanced non-small cell lung cancer unsuitable for platinum-doublet chemotherapy	Atezolizumab (Tecentriq; MPDL3280A)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2022	View \| Download
Atezolizumab for resected non-small cell lung cancer - adjuvant	Atezolizumab (Tecentriq; MPDL3280A)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2020	View \| Download
Atezolizumab for stage IV non-squamous or squamous non-small cell lung cancer	Atezolizumab (Tecentriq; MPDL3280A)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2019	View \| Download
Atezolizumab in addition to Carboplatin or Cisplatin and Pemetrexed for Stage IV non-squamous non-small cell lung cancer (NSCLC)	Atezolizumab (Tecentriq; MPDL3280A) , Carboplatin (Paraplatin) , Cisplatin (Platinol) , Pemetrexed (Alimta; pemetrexed ditromethamine dihydrate; pemetrexed ditrometamol; pemetrexed disodium)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2018	View \| Download